title: Immunoproteomics: current technology and applications.
abstract: The varied landscape of the adaptive immune response is determined by the peptides presented by immune cells, derived from viral or microbial pathogens or cancerous cells. The study of immune biomarkers or antigens is not new and classical methods such as agglutination, enzyme-linked immunosorbent assay, or Western blotting have been used for many years to study the immune response to vaccination or disease. However, in many of these traditional techniques, protein or peptide identification has often been the bottleneck. Recent advances in genomics and proteomics, has led to many of the rapid advances in proteomics approaches. Immunoproteomics describes a rapidly growing collection of approaches that have the common goal of identifying and measuring antigenic peptides or proteins. This includes gel based, array based, mass spectrometry, DNA based, or in silico approaches. Immunoproteomics is yielding an understanding of disease and disease progression, vaccine candidates, and biomarkers. This review gives an overview of immunoproteomics and closely related technologies that are used to define the full set of antigens targeted by the immune system during disease.
authors: Human Health Therapeutics, National Research Council Canada, Ottawa, ON, Canada.
authors: Kelly M
authors: KM
authors: Fulton
authors: Susan M
authors: SM
authors: Twine
mesh_terms: D056704:Adaptive Immunity / Q000276:immunology; D000818:Animals; D000941:Antigens / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007107:Immune System / Q000378:metabolism; D040901:Proteomics / Q000379:methods*
chemical_list: D000941:Antigens